News | December 30, 2025
Italfarmaco and JCR Pharmaceuticals partner to bring Duchenne therapy to Japan
The partnership also sets the stage for broader collaboration on rare disease treatments
The partnership also sets the stage for broader collaboration on rare disease treatments
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
Singlera and Pure Medical will team up with local universities, hospital networks, and national healthcare systems across Western Europe for research studies
These observations are procedural in nature and the company does not anticipate any impact on supply of its commercial products
Under the terms of the deal, AstraZeneca gains exclusive rights to JAB-23E73 outside of mainland China
NUFYMCO BLA has been approved by the USFDA
The new powder formulation gives children and adults living with Rett syndrome greater flexibility and choice in dose volume and taste
This partnership strengthens LMS as a leading CDMO supplier of peptide materials for both innovator and generic markets
The Phase 2 study tested two dose levels of pumitamig alongside four standard chemotherapy regimens across first
Formycon AG will develop, register, manufacture and supply the product, while Zydus Lifesciences Global FZE, United Arab Emirates will be responsible for the commercialization of FYB206 in the defined territories
Subscribe To Our Newsletter & Stay Updated
